New drug ABBV-701 put to the test in healthy people
NCT ID NCT06895343
First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This early-stage study tests a single dose of ABBV-701 in about 100 healthy adults from Western and Asian backgrounds. The main goal is to check for side effects and measure how the drug moves through the body. Participants receive either the drug or a placebo, and no direct health benefit is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acpru /Id# 273354
Grayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 278431
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.